Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-11-25 Sale | 2024-11-25 9:00 pm | Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER | 12,090 | $18.3 | $221,258 | 69,927 (Direct) | View |
| 2024-02-01 Sale | 2024-02-02 4:05 pm | Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER | 2,820 | $8.5312 | $24,058 | 77,017 (Direct) | View |
| 2024-01-23 Sale | 2024-01-25 4:10 pm | Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER | 910 | $9.0684 | $8,252 | 41,337 (Direct) | View |
| 2023-05-10 Sale | 2023-05-12 4:06 pm | Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, Chief Accounting Officer | 558 | $16.49 | $9,200 | 42,247 (Direct) | View |
| 2023-02-01 Sale | 2023-02-02 6:53 pm | Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, Chief Accounting Officer | 2,031 | $21.87 | $44,419 | 62,805 (Direct) | View |
| 2023-01-24 Sale | 2023-01-26 4:05 pm | Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, Chief Accounting Officer | 1,097 | $21.86 | $23,976 | 34,836 (Direct) | View |
| 2022-09-13 Sale | 2022-09-15 4:05 pm | Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, Chief Accounting Officer | 349 | $28 | $9,772 | 35,933 (Direct) | View |
| 2022-05-10 Sale | 2022-05-12 8:44 pm | Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, Chief Accounting Officer | 881 | $21.72 | $19,134 | 35,733 (Direct) | View |
| 2022-01-31 Sale | 2022-02-02 4:22 pm | Travere Therapeutics Inc. | TVTX | Calvin Sandra VP, Corp Controller and CAO | 798 | $26.51 | $21,152 | 54,114 (Direct) | View |
| 2022-01-24 Sale | 2022-01-26 4:38 pm | Travere Therapeutics Inc. | TVTX | Calvin Sandra VP, Corp Controller and CAO | 934 | $24.58 | $22,955 | 28,662 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-11-25 Exercise | 2024-11-25 9:00 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER | 15,000 | $12.67 | 69,927 (Direct) | View |
| 2024-11-25 Exercise | 2024-11-25 9:00 pm | N/A 2025-01-02 | Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER | 15,000 | $0 | 69,927 (Direct) | View |
| 2024-01-31 Option Award | 2024-02-02 4:05 pm | N/A 2034-01-30 | Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER | 38,500 | $0 | 77,017 (Direct) | View |
| 2023-01-31 Option Award | 2023-02-02 6:53 pm | N/A 2033-01-30 | Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, Chief Accounting Officer | 30,000 | $0 | 62,805 (Direct) | View |
| 2022-01-31 Option Award | 2022-02-02 4:22 pm | N/A 2032-01-30 | Travere Therapeutics Inc. | TVTX | Calvin Sandra VP, Corp Controller and CAO | 26,250 | $0 | 54,114 (Direct) | View |
Ownership | 2021-09-23 6:14 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Calvin Sandra VP, Corp Controller and CAO | 0 | $0 | 136,254 (Direct) | View |